Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Manhattan Associates, Lowers Price Target to $244

Author: Benzinga Newsdesk | October 22, 2025 11:53am
Barclays analyst Guy Hardwick maintains Manhattan Associates (NASDAQ:MANH) with a Overweight and lowers the price target from $247 to $244.

Posted In: MANH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist